Drugmakers are becoming much more cautious with their budgets, WebMD executives said.
When discussing the nation's ability to stomach orphan drug costs, an analyst has called the price tag "the straw that breaks the camel's back."
Teva Pharmaceutical Industries' Copaxone is by far the top-selling drug, bringing in $3.2 billion in U.S. sales in 2015.
A loaded hemophilia A drug market is an indication patients in and around it are well-served, but that hasn't stopped contenders such as Roche's emicizumab.
The FDA approves Valeant's psoriasis drug; PhRMA to review its membership criteria; Lions Health announces pharma and health and wellness jury presidents
Novo Nordisk appoints new CEO, and more people moves for you to know about
Pharma execs raise concerns about Trump's plans for the FDA; Merck ends study of experimental Alzheimer's drug; Amgen seeks new indication for Blincyto
Acorda CEO Ron Cohen applauded Marathon's move to pause the commercial activities for its new DMD drug.
More older Americans are taking at least three psychiatric drugs; Marathon to pause launch of Emflaza; Aetna and Humana call off deal
The drugmaker worked with creative agency BBDO and PR firm Marina Maher Communications to develop the campaign.
Sanofi to sell five OTC drugs to Ipsen; Teva reports 33% revenue growth in Q4; Regeneron issued subpoena about support of nonprofits
The company acquired Everyday Health in December.
The new venture aims to provide clients with global reach.
Industry files petition over FDA off-label draft guidance; Marathon secures new DMD drug approval; Price confirmed as head of HHS
Court to allow Sanofi and Regeneron to market Praluent during appeal; Xarelto is effective in treating artery disease; VP advocates for right-to-try laws
Allergan said it would increase its investment in DTC after reporting slowing sales for its double-chin injection.
If generic versions by Mylan, Hikma, and Vectura are approved mid-year, GSK expects sales of Advair to be flat or decline.
The drugmaker is planning a commercial boost for its HIV-prevention drug.
Featured Work: Kennedy Health brings sophisticated healthcare to South Jersey, and we wanted this ...
- Top 25 rare disease brands, by sales
- Five things for pharma marketers to know: Monday, February 13, 2016
- Merck's DTC ad for Keytruda hints at more cancer brands turning to TV
- Five things for pharma marketers to know: Wednesday, February 15, 2017
- Five things for pharma marketers to know: Thursday, February 16, 2017